US DEA approved a study of the influence of hemp on PTR
Federal Agency against Drugs (Drug Enforcement Administration, DEA), officially gave his consent to the conduct of clinical trials of drugs from cannabis as a means for the treatment of post-traumatic stress disorder (MFR) of the psyche of combat veterans.
The study involved 76 people will be affected by the shape of the PTR is not amenable to other therapies, divided into several control groups, which will suffer from the several varieties of hemp, with different concentrations of tetrahydrocannabinol (THC) and cannabidiol (CBD) as well as placebo. The aim of the study will be the definition of positive and negative effects caused by the use of different types of psychoactive hemp, and identification of their effective dosage, if hemp does show its efficacy in the treatment of this disease. The study itself was funded by a Colorado State Ministry of Health grant, in the amount of $ 2,000,000.
According to experts, this study will be the first of its kind officially approved by the DEA and the US health service clinical trial the effectiveness of cannabis in medicine in her vegetable suitable for use form.
"We are actively working on obtaining the rights to the clinical trial of medical cannabis in 2010, under the program of public health service, which allows scientists to study the effects of" experimental drugs in a controlled environment, "according to a press release from the director of the department of clinical studies the MAPS, Amy Emerson." Finally, the we were able to get all the necessary permits for carrying out the test and now we can start looking for participants. This experiment will be the first important step towards the expansion of the study of the properties suitable for the use of various forms of psychoactive cannabis in the treatment of PTR, as well as other diseases. "
Comment of the Association "Ukrainian industrial hemp"
It should be noted that MAPS was able to obtain permission to carry out the tests as soon as the federal policy announced Center for Disease Control and Sanitary Service of his interest in the study of medical cannabis properties in an open letter, published in January 2016.
Information taken from the site http://tku.org.ua